معرفی
Carlotta Marianecci is a Full Professor at the Department of Pharmaceutical Chemistry and Technology, Sapienza University of Rome since 2022. She serves as Director of the Specialization School in Chemical Risk Assessment and Management since November 2023 and teaches courses including Pharmaceutical Regulatory Technology, Ethics of Innovative Formulations, and Nanotechnologies for Drug Delivery in the Pharmacy program. Her office is located in Room 260 on the 2nd floor of the VECF building, with office hours on Thursdays 11-13 and Fridays 12-14.
Professor Marianecci's research focuses on advanced drug delivery systems, specializing in the preparation and characterization of vesicular systems (both phospholipidic and non-phospholipidic), nanoemulsions, and nanobubbles for therapeutic, diagnostic, and theranostic applications. Her work spans multiple pharmaceutical applications including topical, ophthalmic, diagnostic, pulmonary, oral, CNS disorders, and cellular targeting. She has pioneered research on pH-sensitive vesicles, chitosan-coated niosomes, and innovative approaches to brain delivery systems.
Her extensive publication record shows a consistent focus on nanocarrier development, with recent work emphasizing clinical translation of nanomedicines, regulatory aspects of nanocarrier development, and specialized delivery systems for cancer therapy, antibacterial applications, and neurological conditions. The research demonstrates sophisticated understanding of physicochemical properties of nanocarriers and their biological interactions.
Scientific Recognition:
- Young Researcher Award 2019 - Dipartimento di Fisiologia e Farmacologia "V. Erspamer", Università Sapienza di Roma
- Member of Editorial Board: "Pharmaceutics" and "Recent Patents on Drug Delivery & Formulation"
- Reviewer for numerous international journals in pharmaceutical sciences
Professor Marianecci has directed 7 research projects funded by Sapienza University since 2009 and has been a member of the PhD committee in Pharmaceutical Sciences since 2012. She has organized numerous national and international conferences and is currently leading the research project "Evaluation of the clinical efficacy of sandalwood oil nanoemulsions loaded with minoxidil and finasteride in the treatment of androgenetic alopecia." Her research group maintains strong focus on both fundamental characterization of nanocarriers and their practical clinical applications.
